Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.

Boxus M, Fochesato M, Miseur A, Mertens E, Dendouga N, Brendle S, Balogh KK, Christensen ND, Giannini SL.

J Virol. 2016 Jun 24;90(14):6314-25. doi: 10.1128/JVI.00449-16. Print 2016 Jul 15.

2.

Comparative preclinical evaluation of AS01 versus other Adjuvant Systems in a candidate herpes zoster glycoprotein E subunit vaccine.

Fochesato M, Dendouga N, Boxus M.

Hum Vaccin Immunother. 2016 Aug 2;12(8):2092-2095. Epub 2016 Mar 2.

3.

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells.

Didierlaurent AM, Collignon C, Bourguignon P, Wouters S, Fierens K, Fochesato M, Dendouga N, Langlet C, Malissen B, Lambrecht BN, Garçon N, Van Mechelen M, Morel S.

J Immunol. 2014 Aug 15;193(4):1920-30. doi: 10.4049/jimmunol.1400948. Epub 2014 Jul 14.

4.

Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice.

Dendouga N, Fochesato M, Lockman L, Mossman S, Giannini SL.

Vaccine. 2012 Apr 26;30(20):3126-35. doi: 10.1016/j.vaccine.2012.01.088. Epub 2012 Feb 10.

PMID:
22326899
5.

Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis.

Koul A, Vranckx L, Dendouga N, Balemans W, Van den Wyngaert I, Vergauwen K, Göhlmann HW, Willebrords R, Poncelet A, Guillemont J, Bald D, Andries K.

J Biol Chem. 2008 Sep 12;283(37):25273-80. doi: 10.1074/jbc.M803899200. Epub 2008 Jul 14.

6.

Diarylquinolines target subunit c of mycobacterial ATP synthase.

Koul A, Dendouga N, Vergauwen K, Molenberghs B, Vranckx L, Willebrords R, Ristic Z, Lill H, Dorange I, Guillemont J, Bald D, Andries K.

Nat Chem Biol. 2007 Jun;3(6):323-4. Epub 2007 May 13.

PMID:
17496888
7.

Structural and functional characterization of the TgDRE multidomain protein, a DNA repair enzyme from Toxoplasma gondii.

Frénal K, Callebaut I, Wecker K, Prochnicka-Chalufour A, Dendouga N, Zinn-Justin S, Delepierre M, Tomavo S, Wolff N.

Biochemistry. 2006 Apr 18;45(15):4867-74.

PMID:
16605254
8.

p53-independent regulation of p21Waf1/Cip1 expression and senescence by Chk2.

Aliouat-Denis CM, Dendouga N, Van den Wyngaert I, Goehlmann H, Steller U, van de Weyer I, Van Slycken N, Andries L, Kass S, Luyten W, Janicot M, Vialard JE.

Mol Cancer Res. 2005 Nov;3(11):627-34.

9.

Disruption of murine Mus81 increases genomic instability and DNA damage sensitivity but does not promote tumorigenesis.

Dendouga N, Gao H, Moechars D, Janicot M, Vialard J, McGowan CH.

Mol Cell Biol. 2005 Sep;25(17):7569-79.

10.

Transcriptional regulation of two stage-specifically expressed genes in the protozoan parasite Toxoplasma gondii.

Kibe MK, Coppin A, Dendouga N, Oria G, Meurice E, Mortuaire M, Madec E, Tomavo S.

Nucleic Acids Res. 2005 Mar 22;33(5):1722-36. Print 2005.

12.

The SAG5 locus of Toxoplasma gondii encodes three novel proteins belonging to the SAG1 family of surface antigens.

Spano F, Ricci I, Di Cristina M, Possenti A, Tinti M, Dendouga N, Tomavo S, Crisanti A.

Int J Parasitol. 2002 Feb;32(2):121-31.

PMID:
11812489
13.

Supplemental Content

Loading ...
Support Center